Rajpurohit Y, Sharma D, Lal M, Soni I
J Cancer Res Clin Oncol. 2024; 150(5):226.
PMID: 38696003
PMC: 11065934.
DOI: 10.1007/s00432-024-05757-8.
Kumar K, Kumar S, Datta K, Fornace Jr A, Suman S
Curr Oncol. 2023; 30(6):5497-5514.
PMID: 37366899
PMC: 10297158.
DOI: 10.3390/curroncol30060416.
Sekihara K, Himuro H, Saito N, Ota Y, Kouro T, Kusano Y
Cancer Cell Int. 2022; 22(1):391.
PMID: 36494817
PMC: 9733259.
DOI: 10.1186/s12935-022-02810-9.
Mladenova V, Mladenov E, Chaudhary S, Stuschke M, Iliakis G
Front Cell Dev Biol. 2022; 10:1016951.
PMID: 36263011
PMC: 9574094.
DOI: 10.3389/fcell.2022.1016951.
Kawanishi M, Fujita M, Karasawa K
Breast Cancer (Auckl). 2022; 16:11782234221080553.
PMID: 35340889
PMC: 8950024.
DOI: 10.1177/11782234221080553.
Comparison of clinical outcomes between carbon ion radiotherapy and X-ray radiotherapy for reirradiation in locoregional recurrence of rectal cancer.
Chung S, Takiyama H, Kang J, Chang J, Min B, Tsuji H
Sci Rep. 2022; 12(1):1845.
PMID: 35115612
PMC: 8813922.
DOI: 10.1038/s41598-022-05809-4.
ANTP-SMACN7 fusion peptide alone induced high linear energy transfer irradiation radiosensitization in non-small cell lung cancer cell lines.
Xie Y, Wang B, Du L, Wang Y, Xu C, Zhang H
Cancer Biol Med. 2021; .
PMID: 34546667
PMC: 9334756.
DOI: 10.20892/j.issn.2095-3941.2020.0569.
Exploiting DNA repair pathways for tumor sensitization, mitigation of resistance, and normal tissue protection in radiotherapy.
Nickoloff J, Taylor L, Sharma N, Kato T
Cancer Drug Resist. 2021; 4:244-263.
PMID: 34337349
PMC: 8323830.
DOI: 10.20517/cdr.2020.89.
Application of Carbon Ion and Its Sensitizing Agent in Cancer Therapy: A Systematic Review.
Wang X, Chen X, Li G, Han X, Gao T, Liu W
Front Oncol. 2021; 11:708724.
PMID: 34290989
PMC: 8287631.
DOI: 10.3389/fonc.2021.708724.
Particle Therapy for Breast Cancer: Benefits and Challenges.
Luo W, Ali Y, Liu C, Wang Y, Liu C, Jin X
Front Oncol. 2021; 11:662826.
PMID: 34026640
PMC: 8131859.
DOI: 10.3389/fonc.2021.662826.
Longitudinal MRI study after carbon ion and photon irradiation: shorter latency time for myelopathy is not associated with differential morphological changes.
Welzel T, Bendinger A, Glowa C, Babushkina I, Jugold M, Peschke P
Radiat Oncol. 2021; 16(1):63.
PMID: 33789720
PMC: 8011205.
DOI: 10.1186/s13014-021-01792-8.
Proton and Heavy Particle Intracranial Radiosurgery.
Lehrer E, Prabhu A, Sindhu K, Lazarev S, Ruiz-Garcia H, Peterson J
Biomedicines. 2021; 9(1).
PMID: 33401613
PMC: 7823941.
DOI: 10.3390/biomedicines9010031.
Simulation of dose distribution and secondary particle production in proton therapy of brain tumor.
Hashemi Z, Tatari M, Naik H
Rep Pract Oncol Radiother. 2020; 25(6):927-933.
PMID: 33088228
PMC: 7551366.
DOI: 10.1016/j.rpor.2020.08.015.
A high-throughput alpha particle irradiation system for monitoring DNA damage repair, genome instability and screening in human cell and yeast model systems.
Stanley F, Berger N, Pearson D, Danforth J, Morrison H, Johnston J
Nucleic Acids Res. 2020; 48(19):e111.
PMID: 33010172
PMC: 7641727.
DOI: 10.1093/nar/gkaa782.
Preliminary study on radiosensitivity to carbon ions in human breast cancer.
Zhang Q, Kong Y, Yang Z, Liu Y, Liu R, Geng Y
J Radiat Res. 2020; 61(3):399-409.
PMID: 32239160
PMC: 7299270.
DOI: 10.1093/jrr/rraa017.
Clustered DNA Double-Strand Breaks: Biological Effects and Relevance to Cancer Radiotherapy.
Nickoloff J, Sharma N, Taylor L
Genes (Basel). 2020; 11(1).
PMID: 31952359
PMC: 7017136.
DOI: 10.3390/genes11010099.
Strategies to Enhance Radiosensitivity to Heavy Ion Radiation Therapy.
Lee Y, Okayasu R
Int J Part Ther. 2019; 5(1):114-121.
PMID: 31773023
PMC: 6871583.
DOI: 10.14338/IJPT-18-00014.1.
The Future of Combining Carbon-Ion Radiotherapy with Immunotherapy: Evidence and Progress in Mouse Models.
Shimokawa T, Ma L, Ando K, Sato K, Imai T
Int J Part Ther. 2019; 3(1):61-70.
PMID: 31772976
PMC: 6871581.
DOI: 10.14338/IJPT-15-00023.1.
Necessities in the Processing of DNA Double Strand Breaks and Their Effects on Genomic Instability and Cancer.
Iliakis G, Mladenov E, Mladenova V
Cancers (Basel). 2019; 11(11).
PMID: 31661831
PMC: 6896103.
DOI: 10.3390/cancers11111671.
Genomic Instability and Carcinogenesis of Heavy Charged Particles Radiation: Clinical and Environmental Implications.
Mortezaee K, Najafi M, Farhood B, Ahmadi A, Shabeeb D, Musa A
Medicina (Kaunas). 2019; 55(9).
PMID: 31540340
PMC: 6780199.
DOI: 10.3390/medicina55090591.